
|Articles|July 14, 2015
New Release Clinical Conductor CTMS
The new Clinical Conductor contains a myriad of enhancements that foster more precise reporting and analysis.
Advertisement
Bio-Optronics announces its Clinical Conductor CTMS has been updated with enhancements that include:
- Adverse Event (AE/SAE) management enhancements (e.g. wizards for reporting, audit trails for review, document uploads, etc.)
- Billing compliance review functionality additions at the site level, as well as the enterprise level for sponsors, CROs, health systems and other networks
- Invoicing features that allow organizations to set invoicing caps, frequencies and much more.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
2
Honing the Power of AI for Next Generation Trial Oversight and Execution
3
The Value of Pragmatic Randomized Clinical Trials: Strategic Approaches for Real-World Impact
4
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
5